EVMN · Evommune, Inc. · Investor Relations
$6.65
-0.27 (-3.90%)
At close · Oct 5
Return incl. dividend (before tax)
Market Cap
$308.12M
Shares
36.29M
Volume · Oct 5
1.37M
Avg daily vol (3M)
701.83K
Press releases and events scraped from the company’s investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.
Past events
| Date | Event | Type |
|---|---|---|
| 2026-06-02 | 2026 Annual Meeting of Stockholders | Shareholder meeting |
| 2026-04-13 | KOL Webinar Highlighting Role of MRGPRX2 in Migraine | Event |
| 2026-02-10 | Evommune EVO301 Top-Line Results from Phase 2a Trial in Moderate-to-Severe Atopic Dermatitis | Event |
Source: https://ir.evommune.com/